Brodalumab: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Brodalumab. Educational only — not medical advice.
Labeled uses
SILIQ® (brodalumab) is indicated for the treatment of moderate to severe plaque psoriasis in adult patients who are candidates for systemic therapy or phototherapy and have failed to respond or have lost response to other systemic therapies.
Source: FDA labeling via NIH DailyMed (set 1a550c33…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.